Compare IQV & FANG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IQV | FANG |
|---|---|---|
| Founded | 1982 | 2007 |
| Country | United States | United States |
| Employees | 93000 | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.3B | 50.1B |
| IPO Year | 2013 | 2012 |
| Metric | IQV | FANG |
|---|---|---|
| Price | $164.74 | $182.83 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 16 | 20 |
| Target Price | ★ $230.56 | $192.89 |
| AVG Volume (30 Days) | 2.4M | ★ 3.1M |
| Earning Date | 05-08-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 2.37% |
| EPS Growth | ★ 4.67 | N/A |
| EPS | ★ 7.84 | 5.73 |
| Revenue | $9,739,000,000.00 | ★ $15,026,000,000.00 |
| Revenue This Year | $6.76 | N/A |
| Revenue Next Year | $5.85 | $8.29 |
| P/E Ratio | ★ $20.74 | $30.89 |
| Revenue Growth | ★ 41.60 | 35.79 |
| 52 Week Low | $134.65 | $114.00 |
| 52 Week High | $247.05 | $186.66 |
| Indicator | IQV | FANG |
|---|---|---|
| Relative Strength Index (RSI) | 36.48 | 63.44 |
| Support Level | $156.43 | $136.41 |
| Resistance Level | $166.38 | N/A |
| Average True Range (ATR) | 6.33 | 6.88 |
| MACD | 1.34 | -0.17 |
| Stochastic Oscillator | 20.98 | 82.07 |
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
Diamondback is a crude oil and natural gas exploration and production firm whose operations represent a pure-play in the US Permian Basin. The company went public in 2012 and has established itself as a top-tier independent producer through disciplined acquisition and operational excellence. The company's most transformational transaction occurred in September 2024 with the completion of its $26 billion merger with Endeavor Energy Resources, which added around 470,000 net acres and doubled Diamondback's total acreage position. Diamondback boasts an enviable position in the Midland sub-basin, with some of the lowest unit costs among its Permian peers.